This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nrg Therapeutics Ltd. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Mark Stewart - Innovator in Therapeutic Compounds
Introduction
Mark Stewart is a notable inventor based in Saffron Walden, GB. He has made significant contributions to the field of therapeutic compounds, particularly in the development of inhibitors for the mitochondrial permeability transition pore (mPTP). His work is crucial in advancing medical science and improving treatment options.
Latest Patents
Mark Stewart holds 1 patent related to his invention titled "Inhibitors of mPTP." This invention pertains to compounds of formula (I) and explores various related aspects that could have a substantial impact on therapeutic applications.
Career Highlights
Throughout his career, Mark has been associated with Nrg Therapeutics Ltd, where he has focused on innovative research and development. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.
Collaborations
Mark has collaborated with notable colleagues, including Neil Miller and Gilles Ouvry. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in their field.
Conclusion
Mark Stewart's contributions to the field of therapeutic compounds exemplify the spirit of innovation and dedication to improving healthcare. His work continues to inspire future advancements in medical science.